Trial intelligence / Profile preview

Comparison of BOTOX vs Dysport in Cervical Dystonia

NCT00528541Phase 4Completed

Sponsor
Allergan
Start
Sep 2007
Primary completion
Sep 2009
Modality
Recombinant Proteins and Enzymes
Countries
5
01

Overview

A Phase 4 trial of onabotulinumtoxinA in cervical dystonia (CD), sponsored by Allergan. Started Sep 2007; status: completed.

02

Drugs

onabotulinumtoxinA
03

Conditions

cervical dystonia (CD)

Beyond the preview

Go deeper on NCT00528541.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00528541.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call